Cantabio Pharmaceuticals Inc (CTBO):企業の財務・戦略的SWOT分析

◆英語タイトル:Cantabio Pharmaceuticals Inc (CTBO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15045
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, used to treat Parkinson’s disease; CB201 is being developing for the treatment of Parkinson’s disease and Alzheimer’s disease and CB301, is used to treat Alzheimer’s disease. Cantabio Pharmaceuticals conducts in house research and development on critical elements of its drug discovery pipeline by utilizing novel technologies and outsourcing generic research activities to contract research organizations. The company operates in Cambridge, the UK and Budapest, Hungary. Cantabio Pharmaceuticals is headquartered in Sunnyvale, California, the US.

Cantabio Pharmaceuticals Inc Key Recent Developments

Oct 01,2018: Cantabio Pharmaceuticals to present latest positive in vivo results from its DJ-1 targeting small molecule Drug Development Program for parkinson s disease at the Milner Therapeutics Symposium at the University of Cambridge UK
Jun 28,2018: Cantabio Announces Publication of Study on Druggability of the Tau protein in ACS Chemical Neuroscience

This comprehensive SWOT profile of Cantabio Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cantabio Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cantabio Pharmaceuticals Inc – Key Information
Cantabio Pharmaceuticals Inc – Overview
Cantabio Pharmaceuticals Inc – Key Employees
Cantabio Pharmaceuticals Inc – Key Employee Biographies
Cantabio Pharmaceuticals Inc – Key Operational Heads
Cantabio Pharmaceuticals Inc – Major Products and Services
Cantabio Pharmaceuticals Inc – History
Cantabio Pharmaceuticals Inc – Company Statement
Cantabio Pharmaceuticals Inc – Locations And Subsidiaries
Cantabio Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cantabio Pharmaceuticals Inc – Business Description
Cantabio Pharmaceuticals Inc – Corporate Strategy
Cantabio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Cantabio Pharmaceuticals Inc – Strengths
Cantabio Pharmaceuticals Inc – Weaknesses
Cantabio Pharmaceuticals Inc – Opportunities
Cantabio Pharmaceuticals Inc – Threats
Cantabio Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cantabio Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cantabio Pharmaceuticals Inc, Key Information
Cantabio Pharmaceuticals Inc, Key Ratios
Cantabio Pharmaceuticals Inc, Share Data
Cantabio Pharmaceuticals Inc, Major Products and Services
Cantabio Pharmaceuticals Inc, History
Cantabio Pharmaceuticals Inc, Key Employees
Cantabio Pharmaceuticals Inc, Key Employee Biographies
Cantabio Pharmaceuticals Inc, Key Operational Heads
Cantabio Pharmaceuticals Inc, Other Locations
Cantabio Pharmaceuticals Inc, Subsidiaries
Cantabio Pharmaceuticals Inc, Key Manufacturing facilities
Cantabio Pharmaceuticals Inc, Key Competitors
Cantabio Pharmaceuticals Inc, SWOT Analysis
Cantabio Pharmaceuticals Inc, Ratios based on current share price
Cantabio Pharmaceuticals Inc, Annual Ratios
Cantabio Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cantabio Pharmaceuticals Inc, Performance Chart
Cantabio Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Cantabio Pharmaceuticals Inc (CTBO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PTT Global Chemical Public Co Ltd (PTTGC):企業の財務・戦略的SWOT分析
    PTT Global Chemical Public Co Ltd (PTTGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Gordon Food Service, Inc.:企業の戦略・SWOT・財務情報
    Gordon Food Service, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • KVK-Tech Inc-製薬・医療分野:企業M&A・提携分析
    Summary KVK-Tech Inc (KVK-Tech) is a manufacturer and marketer generic drugs. The company's product portfolio includes benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phendimetrazine tartrate, phentermine HCL, prome …
  • NetSuite Inc.:企業の戦略的SWOT分析
    NetSuite Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • AeroCentury Corp:企業の戦略・SWOT・財務分析
    AeroCentury Corp - Strategy, SWOT and Corporate Finance Report Summary AeroCentury Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Windflow Technology Ltd (WTL):企業の財務・戦略的SWOT分析
    Windflow Technology Ltd (WTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Xiangxue Pharmaceutical Co Ltd (300147):製薬・医療:M&Aディール及び事業提携情報
    Summary Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company’s products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare suppleme …
  • DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • Northwest Biotherapeutics Inc (NWBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Usg Corporation
    Usg Corporation - Strategy, SWOT and Corporate Finance Report Summary Usg Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PharmAust Ltd (PAA)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory suppo …
  • Cenovus Energy Inc (CVE)-石油・ガス分野:企業M&A・提携分析
    Summary Cenovus Energy Inc (Cenovus Energy) is an oil and gas company, which explores, develops and produces crude oil and natural gas. The company also carries out processing of natural gas liquids. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves. Its project …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Tan Chong Motor Holdings Berhad (TCHONG):企業の財務・戦略的SWOT分析
    Tan Chong Motor Holdings Berhad (TCHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • BG Medicine Inc:医療機器:M&Aディール及び事業提携情報
    Summary BG Medicine Inc (BGM), formerly Beyond Genomics Inc is a medical device company that discovers, develops and delivers diagnostic products. The company offers diagnostis products to aid in the clinical management of heart failure and related disorders. It offers BGM Galectin-3 test, an in vit …
  • Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Raysearch Laboratories AB (RAY B):企業の財務・戦略的SWOT分析
    Summary RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raystation and raycare. Its services include installation, support, training and training schedule. …
  • Alps Industries Ltd.:企業の戦略・SWOT・財務分析
    Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JXTG Holdings Inc (5020):企業の財務・戦略的SWOT分析
    JXTG Holdings Inc (5020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Raisio plc:企業の戦略・SWOT・財務情報
    Raisio plc - Strategy, SWOT and Corporate Finance Report Summary Raisio plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆